OneLegacy CEO Addresses Healthcare, Business and Government Leaders in China Regarding the Importance of Organ and Tissue Donation
LOS ANGELES--(BUSINESS WIRE)--Sep 24, 2018--OneLegacy CEO Tom Mone has joined with a distinguished international faculty in addressing healthcare, business and government leaders from across China’s Southern Yunnan province on best practices in organ and tissue donation. Mone made his remarks in Kunming, the capital city of the Yunnan province that is working to become that country’s first combined organ procurement organization (OPO) and tissue bank.
Mone’s trip to Kunming included follow-up training of 60 Chinese physicians from 30 hospitals in southern Yunnan and built on last year’s visit, where Mone joined the transplant procurement management (TPM) team (out of Barcelona, Spain) in their ongoing training of Kunming-region hospitals and staffs on the processes, need for, values of, and best practices in organ donation. The TPM program has been the world’s leading training program since the late 1980s and builds on the formal clinical and hospital development and family-approach work that has helped Spain become the world’s leading organ donation country for the past 40 years. Mone has been working with the TPM team since 2007.
In citing best practices, Mone highlighted OneLegacy’s dedicated transplant recovery center, the first such center of its kind in California. Opened earlier this year in Redlands, the facility handles organ, eye and tissue donation and provides renewed hope to the thousands of individuals waiting to receive the gift of life.
“This center allows us to save more lives by providing facilities that exceed hospital and FDA standards while removing time and scheduling constraints for recovery and transplantation while, at the same time, freeing hospital ICU beds and operating rooms for their emergency patients,” said Mone. “The center also reduces the costs of recovery while providing special care for donor families.”
In calling for greater worldwide awareness of this pressing need, Mone told the gatherings “The simple truth is that organ, eye and tissue donation saves and heals lives.” He called that a goal “that knows no national, ethnic or religious boundaries” as he shared his road-tested experience as it relates to the ongoing challenges of organ donation and provided suggestions on how to make the donor-management process more effective at the local level.
In 2015 the Chinese government banned any import of tissue from other countries in order to promote the development of a voluntary donation system within its borders. Additionally, for years the Chinese government had used executed prisoner organs for transplants but were convinced to halt that practice thanks to efforts by its Vice Minister of Health Jiefu Huang, M.D., a former transplant surgeon; the support of the President of China and western transplant leaders (including Mone); the World Health Organization; and the Transplantation Society.
“As a result of pressures from the international transplant and donation communities – combined with an internal recognition of the ethical and moral challenges involved – the Chinese government ended its use of executed prisoners as a source of organs for transplant and have moved to a voluntary, altruistic organ donation program,” said Mone. “It is incumbent on those of us who have successful donation practices to help ensure that donation everywhere meets the high standards that earn the public trust that is essential to maintain and grow lifesaving donation.”
Since the change, voluntary deceased donors have increased from less than 1,000 to 5,148 in the past three years; and local experts say that there is every reason to anticipate the continued increase in donors. As a result, China has become the country with the second highest number of voluntary deceased donors in the world.
The Donation and Transplantation Institute’s education program, which Mone addressed, is a nonprofit foundation that brings together experts in the field from Spain, Europe and America to advise and support the implementation of projects in organ, tissue, and cell donation and transplant and to foster a wide network for research in the field.
“My trip to China was all about spreading the message about the importance of organ donation and learning from each other on how we can all do a better job in positively impacting donation activity in our own communities and in our own countries,” said Mone. “OneLegacy is pleased to be a part of the international and Chinese team that is sharing best practices that have helped China increase donation 25 percent in the past three years.”
OneLegacy is a nonprofit organization dedicated to saving and healing lives through organ, eye and tissue donation in seven counties in Southern California: Los Angeles, Orange, Riverside, San Bernardino, Ventura, Santa Barbara and Kern. Serving more than 200 hospitals, 11 transplant centers and a diverse population of nearly 20 million, OneLegacy is the largest organ, eye and tissue recovery organization in the world. For more information, visit onelegacy.org, like us on Facebook or follow us on Twitter.
View source version on businesswire.com:https://www.businesswire.com/news/home/20180924005213/en/
CONTACT: For OneLegacy
KEYWORD: UNITED STATES ASIA PACIFIC NORTH AMERICA CHINA CALIFORNIA
INDUSTRY KEYWORD: OTHER CONSUMER SURGERY HEALTH HOSPITALS PHILANTHROPY OTHER PHILANTHROPY CONSUMER
Copyright Business Wire 2018.
PUB: 09/24/2018 11:15 AM/DISC: 09/24/2018 11:15 AM